Should we screen for masked hypertension in patient with vascular disease?

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 333-338

  Delsart, Pascal ^a   Marboeuf, Philippe ^a   Delhaye, Cedric ^a   Lemesle, Gilles ^a   Mounier Vehier, Claire ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Blood pressure; Masked hypertension; Monitoring; Vascular disease

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MASKED HYPERTENSION; MEAN ARTERIAL PRESSURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PULSE PRESSURE; RISK ASSESSMENT; SCREENING TEST; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; HOSPITAL DISCHARGE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PREDICTION AND FORECASTING; PROGNOSIS; TIME;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS;

EID: 77955886437     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/vhrm.s9980     Document Type: Article

References (21)

1. Dzau VJ, Antman EM, Black HR, et al. The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006;114(25): 2850-2870.
2. Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: A systematic review. J Hypertens. 2008;26(9): 1715-1725.
3. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: Association with target-organ damage. Pediatr Nephrol. 2005;20(8): 1151-1155.
4. Ohman EM, Bhatt DL, Steg PG, et al; REACH Registry Investigators. The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events - study design. Am Heart J. 2006;151(4):786.e1-e10.
5. Yap YG, Duong T, Bland JM, et al. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: An insight from survival trials. J Hypertens. 2007;25(2):307-313.
6. Arima H, Chalmers J, Woodward M, et al; PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: The PROGRESS trial. J Hypertens. 2006;24(6):1201-1208.
7. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24(17):1601-1610.
8. Weinsaft JW. Effect of ramipril on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-153.
9. Fox KM. European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362(9386):782-788.
10. Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens. 2007;25(9):1751-1762.
11. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47(5): 846-853.
12. Kotsis V, Stabouli S, Toumanidis S, et al. Target organ damage in "white coat hypertension" and "masked hypertension". Am J Hypertens. 2008;21(4):393-399.
13. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring: 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-515.
14. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342-1349.
15. Björklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003;107(9):1297-1302.
16. Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens. 2006;24(12):2365-2370.
17. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
18. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11(9):CR403-CR409.
19. Obara T, Ohkubo T, Funahashi J, Kikuya M, Asayama K, Metoki H. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens. 2005;23(9):1653-1660.
20. Verberk WJ, Kessels AG, de Leeuw PW. Prevalence, causes, and consequences of masked hypertension: A meta-analysis. Am J Hypertens. 2008;21(9):969-975.
21. Pickering TG, Gerin W, Schwartz JE, Spruill TM, Davidson KW Franz. Volhard lecture: Should doctors still measure blood pressure? The missing patients with masked hypertension. J Hypertens. 2008;26(12):2259-2267.